Versant Capital Management’s CareDx CDNA Stock Holding History

Versant Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.3K	Hold	958	–	–	﹤0.01%	1764
2026 Q1	$16.6K	Buy	958 +87	+10%	+$1.65K	﹤0.01%	1902
2025 Q4	$16.4K	Hold	871	–	–	﹤0.01%	1754
2025 Q3	$12.7K	Buy	871 +776	+817%	+$11.1K	﹤0.01%	1830
2025 Q2	$1.86K	Buy	+95	New	+$1.69K	﹤0.01%	2397

Other funds holding CDNA

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Chicago Trust Grayslake, Illinois $690M AUM 33.05% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return